143 related articles for article (PubMed ID: 16831129)
1. The clinical pharmacology of therapeutic monoclonal antibodies in the treatment of malignancy; have the magic bullets arrived?
Newsome BW; Ernstoff MS
Br J Clin Pharmacol; 2008 Jul; 66(1):6-19. PubMed ID: 18503606
[TBL] [Abstract][Full Text] [Related]
2. The Emerging Landscape of Immune Cell Therapies.
Weber EW; Maus MV; Mackall CL
Cell; 2020 Apr; 181(1):46-62. PubMed ID: 32243795
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic applications of monoclonal antibodies.
Berger M; Shankar V; Vafai A
Am J Med Sci; 2002 Jul; 324(1):14-30. PubMed ID: 12120821
[TBL] [Abstract][Full Text] [Related]
4. Promises and pitfalls for recombinant oligoclonal antibodies-based therapeutics in cancer and infectious disease.
Corti D; Kearns JD
Curr Opin Immunol; 2016 Jun; 40():51-61. PubMed ID: 26995095
[TBL] [Abstract][Full Text] [Related]
5. The expanding role of immunopharmacology: IUPHAR Review 16.
Tiligada E; Ishii M; Riccardi C; Spedding M; Simon HU; Teixeira MM; Cuervo ML; Holgate ST; Levi-Schaffer F
Br J Pharmacol; 2015 Sep; 172(17):4217-27. PubMed ID: 26173913
[TBL] [Abstract][Full Text] [Related]
6. Nanobodies in cytokine‑mediated immunotherapy and immunoimaging (Review).
Zhang X; Wang J; Tan Y; Chen C; Tang S; Zhao S; Qin Q; Huang H; Duan S
Int J Mol Med; 2024 Feb; 53(2):. PubMed ID: 38063273
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Monoclonal Antibodies against Cancer: Present and Future.
Delgado M; Garcia-Sanz JA
Cells; 2023 Dec; 12(24):. PubMed ID: 38132155
[TBL] [Abstract][Full Text] [Related]
8. The past, present and future of immunotherapy against tumor.
Jiang T; Zhou C
Transl Lung Cancer Res; 2015 Jun; 4(3):253-64. PubMed ID: 26207213
[TBL] [Abstract][Full Text] [Related]
9. Combination of Id2 Knockdown Whole Tumor Cells and Checkpoint Blockade: A Potent Vaccine Strategy in a Mouse Neuroblastoma Model.
Chakrabarti L; Morgan C; Sandler AD
PLoS One; 2015; 10(6):e0129237. PubMed ID: 26079374
[TBL] [Abstract][Full Text] [Related]
10. Failure to upregulate cell surface PD-1 is associated with dysregulated stimulation of T cells by TGN1412-like CD28 superagonist.
Thaventhiran T; Alhumeed N; Yeang HX; Sethu S; Downey JS; Alghanem AF; Olayanju A; Smith EL; Cross MJ; Webb SD; Williams DP; Bristow A; Ball C; Stebbings R; Sathish JG
MAbs; 2014; 6(5):1290-9. PubMed ID: 25517314
[TBL] [Abstract][Full Text] [Related]
11. Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy.
Aranda F; Vacchelli E; Eggermont A; Galon J; Fridman WH; Zitvogel L; Kroemer G; Galluzzi L
Oncoimmunology; 2014 Jan; 3(1):e27297. PubMed ID: 24701370
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory monoclonal antibodies combined with peptide vaccination provide potent immunotherapy in an aggressive murine neuroblastoma model.
Williams EL; Dunn SN; James S; Johnson PW; Cragg MS; Glennie MJ; Gray JC
Clin Cancer Res; 2013 Jul; 19(13):3545-55. PubMed ID: 23649004
[TBL] [Abstract][Full Text] [Related]
13. Medical applications of leukocyte surface molecules--the CD molecules.
Zola H
Mol Med; 2006; 12(11-12):312-6. PubMed ID: 17380197
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of immunostimulatory monoclonal antibodies.
Gray JC; Johnson PW; Glennie MJ
Clin Sci (Lond); 2006 Aug; 111(2):93-106. PubMed ID: 16831129
[TBL] [Abstract][Full Text] [Related]
15. Immunostimulatory monoclonal antibodies for cancer therapy.
Melero I; Hervas-Stubbs S; Glennie M; Pardoll DM; Chen L
Nat Rev Cancer; 2007 Feb; 7(2):95-106. PubMed ID: 17251916
[TBL] [Abstract][Full Text] [Related]
16. Cancer therapeutic monoclonal antibodies targeting lymphocyte co-stimulatory pathways.
Zhu Y; Chen L
Curr Opin Investig Drugs; 2003 Jun; 4(6):691-5. PubMed ID: 12901227
[TBL] [Abstract][Full Text] [Related]
17. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
Khawli LA; Hu P; Epstein AL
Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
[TBL] [Abstract][Full Text] [Related]
18. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
Peggs KS; Quezada SA; Allison JP
Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
[TBL] [Abstract][Full Text] [Related]
19. Using monoclonal antibodies to stimulate antitumor cellular immunity.
Durrant LG; Pudney VA; Spendlove I
Expert Rev Vaccines; 2011 Jul; 10(7):1093-106. PubMed ID: 21806402
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
